SCHEMBL24264263

SCHEMBL24264263

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccc(-c5cccc6c5oc5ccccc56)cc34)nc(-c3cccc4c5ccccc5n(-c5ccccc5)c34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.41
PRKDC P78527 3/20 0.40
GGPS1 O95749 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
CHEK2 O96017 1/20 0.32
MAPT P10636 3/20 0.32
TSHR P16473 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CB P42338 1/20 0.32
PRMT5 O14744 1/20 0.31
WDR77 Q9BQA1 1/20 0.31
KDM4E B2RXH2 2/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PTPRF P10586 2/20 0.31
PTPN2 P17706 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24097615 0.97 ALOX5 (0.43) ALOX5PRKDCGGPS1PTGES2MAPT
SCHEMBL23947310 0.96 ALOX5 (0.39) ALOX5PRKDCGGPS1PTGES2SIRT2
SCHEMBL23947550 0.96 ALOX5 (0.39) ALOX5PRKDCGGPS1PTGES2SIRT2
SCHEMBL23947514 0.95 ALOX5 (0.38) ALOX5PRKDCGGPS1PTGES2SIRT2
SCHEMBL23947323 0.94 ALOX5 (0.38) ALOX5PRKDCGGPS1SIRT2SIRT1
SCHEMBL23947279 0.94 ALOX5 (0.38) ALOX5PRKDCGGPS1SIRT2SIRT1
SCHEMBL23947520 0.93 ALOX5 (0.41) ALOX5PRKDCGGPS1PTGES2MAPT
SCHEMBL24264032 0.93 SIRT2 (0.35) PRKDCSIRT2SIRT1CHEK2MAPT
SCHEMBL24264432 0.93 SIRT2 (0.35) PRKDCSIRT2SIRT1CHEK2MAPT
SCHEMBL24210339 0.93 ALOX5 (0.37) ALOX5PRKDCSIRT2SIRT1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-11-28 US disclosed
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-11-28 US disclosed
US-20220059778-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220059778-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, TRPC1, CYP1A1 ALOX5 1152/4885PRKDC 4335/4885GGPS1 144/4885
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, TRPC1, CYP1A1 ALOX5 1152/4885PRKDC 4335/4885GGPS1 144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.